Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 24657003

Neoadjuvant and adjuvant trastuzumab in patients with HER2-positive locally advanced breast cancer (NOAH): follow-up of a randomised controlled superiority trial with a parallel HER2-negative cohort.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Lancet Oncol
Publication date
2014 May
First author
Gianni L

This record carries publication-notice metadata. Review the notices below before relying on it.

Publication notices

absence is not clearance
true
has correction metadata
true
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Oncol. 2014 May;15(6):550-2. doi: 10.1016/S1470-2045(14)70116-0.
    note
    Source null
    related pmid
    24657002
    relationship
    Comment in
  2. citation
    Lancet Oncol. 2018 Dec;19(12):e667. doi: 10.1016/S1470-2045(18)30852-0.
    note
    Source null
    related pmid
    30507430
    relationship
    Erratum in

Authors and identifiers

  1. name
    Gianni L
    type
    Author
  2. name
    Eiermann W
    type
    Author
  3. name
    Semiglazov V
    type
    Author
  4. name
    Lluch A
    type
    Author
  5. name
    Tjulandin S
    type
    Author
  6. name
    Zambetti M
    type
    Author
  7. name
    Moliterni A
    type
    Author
  8. name
    Vazquez F
    type
    Author
  9. name
    Byakhov MJ
    type
    Author
  10. name
    Lichinitser M
    type
    Author
  11. name
    Climent MA
    type
    Author
  12. name
    Ciruelos E
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Gianni L
    type
    Author
  2. name
    Eiermann W
    type
    Author
  3. name
    Semiglazov V
    type
    Author
  4. name
    Lluch A
    type
    Author
  5. name
    Tjulandin S
    type
    Author
  6. name
    Zambetti M
    type
    Author
  7. name
    Moliterni A
    type
    Author
  8. name
    Vazquez F
    type
    Author
  9. name
    Byakhov MJ
    type
    Author
  10. name
    Lichinitser M
    type
    Author
  11. name
    Climent MA
    type
    Author
  12. name
    Ciruelos E
    type
    Author
bibliography ids
  1. nci-bib-dea7a6a238c9ee2316acfd1c
book metadata
content sha256
41c413491d5058a0cf86ebd31148f63822e3a5dae66ffe73d3ccb6fb4e7c4744
document type
citation
dois
  1. 10.1016/S1470-2045(14)70080-4
electronic publication date
display
2014 Mar 20
precision
day
year
2014
evidence scope
bibliographic_metadata_only
id
pubmed:24657003
immutable id
pubmed:24657003@41c413491d5058a0cf86ebd31148f63822e3a5dae66ffe73d3ccb6fb4e7c4744
journal
abbreviation
Lancet Oncol
issn electronic
1474-5488
issn print
1470-2045
issue
6
name
The Lancet. Oncology
nlm unique id
100957246
pages
640-7
volume
15
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
true
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Oncol. 2014 May;15(6):550-2. doi: 10.1016/S1470-2045(14)70116-0.
    note
    Source null
    related pmid
    24657002
    relationship
    Comment in
  2. citation
    Lancet Oncol. 2018 Dec;19(12):e667. doi: 10.1016/S1470-2045(18)30852-0.
    note
    Source null
    related pmid
    30507430
    relationship
    Erratum in
outcomes validated
false
pmid
24657003
provenance
batch id
063b6c38419f18d4021f
provider
NCBI PubMed ESummary
record sha256
0ead434fdb7b61646bd311f7a3de87533624a0627967222d1e6729743ffafd6d
response sha256
5abcae41e9384a85f92695ef76b244ffd933f07a58a51082c160af8743d196ad
retrieved at
2026-09-09T23:47:02.607425+00:00
publication date
display
2014 May
precision
month
year
2014
publication types
  1. Clinical Trial, Phase III
  2. Journal Article
  3. Multicenter Study
  4. Randomized Controlled Trial
  5. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/24657003/
title
Neoadjuvant and adjuvant trastuzumab in patients with HER2-positive locally advanced breast cancer (NOAH): follow-up of a randomised controlled superiority trial with a parallel HER2-negative cohort.

Preserved source evidence · Not medical advice